Skip to main content
Search

University of Helsinki

9 related articles

Subscribe to updates
  1. bioRxiv

    Brieno turns raw nanopore current into discrete tokens, then pretrains a Transformer that reads methylation with few labels

    Raw nanopore current is continuous and has no native token vocabulary, and prior analyses built a separate model per task. Brieno first compresses the signal into discrete tokens with residual vector quantization, then pretrains a Transformer by masked-token prediction on 118 million reads, so frozen or fine-tuned features serve species identification, barcode demultiplexing, basecalling and methylation detection. On held-out runs, fine-tuned Brieno reached a read-level CpG 5mC AUROC of 0.978, above the 0.975 of Dorado's dedicated 5mCG model.

  2. bioRxiv

    Cell-line drug sensitivity must reach patients: MODAE+ aligns the two domains while keeping tumour lineage, and its predicted sensitivity tracks survival

    Transferring drug sensitivity from cancer cell lines to patient tumours is hard because aligning the two domains can erase tumour-lineage structure. MODAE+ jointly optimizes domain alignment, deconfounding, drug-response prediction, survival prediction and lineage classification in one shared latent space, with adaptive multitask weighting to balance them. On matched treated TCGA subsets, its predicted sensitivity reached a 41.5% Cox-significant rate for overall survival, versus 4.9% for CODE-AE-ADV.

  3. Nature

    Chromatin-level QTLs in immune cells recover 4.5–22.6% more disease signals than expression QTLs alone

    Across 3.47 million peripheral blood mononuclear cell nuclei from 922 donors, chromatin accessibility was treated as a heritable molecular trait, yielding 243,225 chromatin accessibility quantitative trait loci (caQTLs) across 28 immune cell types, 60% of them cell-type specific. Compared with single-cell expression QTLs (eQTLs), these loci colocalized with 4.5–22.6% more genome-wide association signals for 16 diseases and 44 blood traits; adding cell-type context, wider windows and multi-causal-variant models raised the share of inflammatory bowel disease loci with colocalization evidence from about 16% to about 65%.

  4. medRxiv

    Lightweight medical CNNs let recurrence order set channel width: brain-MRI parameters fall up to 50.4%, with accuracy gains and losses

    Channel widths in a lightweight medical image classifier no longer have to be set by hand or found by architecture search. Fibonacci-Net allocated filters by a fixed second-order recurrence, leaving little control over capacity. Scaled m-BonacciNet derives a scaling coefficient from the dominant root of the m-Bonacci recurrence, narrows the original channel vector, and uses depthwise separable convolutions in the last blocks; on 15-class brain MRI, the Tribonacci variant reached 96.09% accuracy and 0.9581 macro F1 with about 0.85 million parameters and 365.69 million FLOPs, though some variants lost accuracy on 4-class brain MRI and CKD ultrasound.

  5. arXiv

    Hyvärinen argues unsupervised learning has no single goal, proposing four goals that are orthogonal or even conflicting

    The paper argues that unsupervised learning, including self-supervised learning, has no single goal or single maximized objective function, and proposes four distinct goals that are partly orthogonal or even conflicting: estimating the distribution, generating new data points, extracting features for downstream tasks, and understanding the data; for each goal it gives a problem statement, representative methods, and validation approaches, noting that understanding depends on identifiability while validation is often the hardest part.

  6. arXiv

    PrivTab embeds a differential-privacy mechanism inside a tabular foundation model, beating DP-LR and DP-MLP on 33 TabArena datasets under moderate-to-strong privacy while cutting fitting time from minutes to about 10 milliseconds

    The authors introduce PrivTab, a tabular foundation model that embeds a differential-privacy mechanism in its architecture: pretrained on simulated datasets, it uses in-context learning to compress sensitive rows into compact, provably private summaries, outperforming DP-LR and DP-MLP on 33 TabArena classification datasets across six privacy regimes under moderate-to-strong privacy, maintaining well-calibrated predictions, and reducing fitting time from minutes to a single forward pass of about 10 milliseconds.

  7. mxDVP identifies over 6,000 proteins from as few as 100 small islet cells and resolves twelve endocrine subtypes in human pancreatic islets

    The authors developed multiplexed Deep Visual Proteomics (mxDVP), an end-to-end workflow combining high-plex imaging, automated computational analysis, and spatially guided ultra-sensitive mass spectrometry, powered by the open-source image analysis framework PIPΣX for whole-slide membrane-aware segmentation, annotation, and laser microdissection export, achieving more than 6,000 protein identifications from as few as 100 small islet cells; applied to human pancreatic islets it segmented over 860,000 cells and resolved twelve endocrine subtypes, including rare polyhormonal and intermediate-state populations showing spatial organization patterns, co-expression of INSM1 and SCG3, and hybrid α/β/δ signatures.

  8. Nature News

    Human-supervised Agentic AI for Hypothesis Generation and Experimental Assistance in Drug Repurposing

    The study developed RepurAgent, a hierarchical multi-agent AI system in which a supervisor agent and a planning agent coordinate four specialized sub-agents (research, prediction, data, and report) through a human-in-the-loop design with episodic memory and retrieval-augmented generation, and validated it across three scenarios spanning the drug repurposing lifecycle: in Acute Myeloid Leukemia a blinded expert evaluation indicated substantially more novel and mechanistically credible candidates than a vanilla LLM baseline; in a retrospective COVID-19 antiviral screen it prioritized compounds with AUC-ROC up to 0.

  9. Artificial intelligence-assisted lead optimization in drug discovery: bridging computational advances and translational challenges

    This review systematically surveys the current landscape of artificial intelligence and machine learning in lead optimization, covering advances in graph neural networks, transformer architectures, diffusion models, and chemical foundation models for molecular design and property prediction, and discusses emerging concepts including data-centric AI, uncertainty quantification, trustworthy AI, the AI optimization paradox, and the shift from molecular prediction toward scientific decision-making, concluding that despite increasing industrial adoption, AI remains dependent on high-quality experimental data, model generalizability, and rigorous experimental validation, and that future progress will depend less on increasingly sophisticated algorithms than on trustworthy AI systems that improve

You’re all caught up